InSeal Medical (Caesarea, Israel) landed the CE Mark of approval in Europe for its InClosure VCD large bore vascular closure device. Procedures such as transcatheter aortic valve replacements that require fairly large devices to be introduced through the vasculature produce substantial access holes that can be difficult to close securely. The InClosure VCD is intended to effectively automate the process and lead to consistent hemostasis.
The device does not require any preparation before the main procedure, and can be used out of the box. It is inserted into punctures between 12 French and 21 French in size and the deployed within the vessel. A flexible membrane held open by a nitinol metal frame that pushes it against the wall keeps the puncture closed. Additionally, the blood pressure pushing on the patch actually helps to make sure the seal is tight.
The biodegradable membrane eventually dissolves into the body after a few months and disappears from the site.
Source: InSeal Medical…